ArticleMedicine2026
Sarcopenia and associated factors in maintenance hemodialysis patients in Vietnam: A cross-sectional study.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sarcopenia is a prevalent complication among patients undergoing maintenance hemodialysis (MHD), contributing to increased mortality, decreased quality of life, and higher healthcare costs. Despite its clinical significance, research on sarcopenia in MHD patients remains limited in Vietnam. This study aims to determine the prevalence of sarcopenia and its associated factors among MHD patients. This cross-sectional study included 106 patients undergoing MHD at Ho Chi Minh City's Hospital for Rehabilitation - Professional Diseases, Vietnam. Sarcopenia was assessed using the Asian Working Group for Sarcopenia 2019 criteria, including handgrip strength, 6-meter walking speed, and skeletal muscle mass index measured by bioelectrical impedance analysis. Sociodemographic, clinical, and biochemical parameters were collected. Statistical analysis was performed using Stata 14.0, and factors associated with sarcopenia were analyzed using prevalence ratios (PRs) with 95% confidence intervals (CIs). Among the study participants, 44 (41.5%) were diagnosed with sarcopenia. Older age (≥60 years; P < .001, PR = 0.36, 95% CI = 0.22-0.58), unemployment (P = .003, PR = 0.19, 95% CI = 0.06-0.56), dialysis vintage (P = .037, PR = 1.63, 95% CI = 1.03-2.58), cardiovascular disease (P = .020, PR = 1.67, 95% CI = 1.09-2.58), low body mass index (<18.5 kg/m2; P = .011, PR = 1.78, 95% CI = 1.14-2.79), and low serum albumin levels (<35 g/L; P = .007, PR = 1.80, 95% CI = 1.18-2.74) were significant associated with sarcopenia. Sarcopenia is highly prevalent among MHD patients and is associated with older age, unemployment, dialysis vintage, cardiovascular disease, low body mass index, and low serum albumin levels. These findings highlight the need for early screening, nutritional interventions, and physical activity programs to mitigate the progression of sarcopenia in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.